These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15533934)

  • 1. DNA topoisomerase II poison TAS-103 transactivates GC-box-dependent transcription via acetylation of Sp1.
    Torigoe T; Izumi H; Wakasugi T; Niina I; Igarashi T; Yoshida T; Shibuya I; Chijiiwa K; Matsuo K; Itoh H; Kohno K
    J Biol Chem; 2005 Jan; 280(2):1179-85. PubMed ID: 15533934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of the human vacuolar H+-ATPase c subunit gene (ATP6L) in response to anticancer agents.
    Torigoe T; Izumi H; Ishiguchi H; Uramoto H; Murakami T; Ise T; Yoshida Y; Tanabe M; Nomoto M; Itoh H; Kohno K
    J Biol Chem; 2002 Sep; 277(39):36534-43. PubMed ID: 12133827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition.
    Fortune JM; Velea L; Graves DE; Utsugi T; Yamada Y; Osheroff N
    Biochemistry; 1999 Nov; 38(47):15580-6. PubMed ID: 10569942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear receptors modulate the interaction of Sp1 and GC-rich DNA via ternary complex formation.
    Husmann M; Dragneva Y; Romahn E; Jehnichen P
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):763-72. PubMed ID: 11104684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA topoisomerases as targets for the anticancer drug TAS-103: primary cellular target and DNA cleavage enhancement.
    Byl JA; Fortune JM; Burden DA; Nitiss JL; Utsugi T; Yamada Y; Osheroff N
    Biochemistry; 1999 Nov; 38(47):15573-9. PubMed ID: 10569941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of USF, Ikaros and Sp proteins in the transcriptional regulation of the human reduced folate carrier B promoter.
    Liu M; Whetstine JR; Payton SG; Ge Y; Flatley RM; Matherly LH
    Biochem J; 2004 Oct; 383(Pt 2):249-57. PubMed ID: 15214842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of human topoisomerase IIalpha expression correlates with relative amounts of specificity factors Sp1 and Sp3 bound at proximal and distal promoter regions.
    Williams AO; Isaacs RJ; Stowell KM
    BMC Mol Biol; 2007 May; 8():36. PubMed ID: 17511886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA topoisomerase inhibitor, etoposide, enhances GC-box-dependent promoter activity via Sp1 phosphorylation.
    Niina I; Uchiumi T; Izumi H; Torigoe T; Wakasugi T; Igarashi T; Miyamoto N; Onitsuka T; Shiota M; Okayasu R; Chijiiwa K; Kohno K
    Cancer Sci; 2007 Jun; 98(6):858-63. PubMed ID: 17441964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coactivators p300 and PCAF physically and functionally interact with the foamy viral trans-activator.
    Bannert H; Muranyi W; Ogryzko VV; Nakatani Y; Flügel RM
    BMC Mol Biol; 2004 Sep; 5():16. PubMed ID: 15350211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of a novel quinoline derivative, TAS-103, with inhibitory effects on topoisomerases I and II.
    Utsugi T; Aoyagi K; Asao T; Okazaki S; Aoyagi Y; Sano M; Wierzba K; Yamada Y
    Jpn J Cancer Res; 1997 Oct; 88(10):992-1002. PubMed ID: 9414662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation into the formation of N- [2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) and 6-[2-(dimethylamino)ethylamino]- 3-hydroxy-7H-indeno[2, 1-C]quinolin-7-one dihydrochloride (TAS-103) stabilised DNA topoisomerase I and II cleavable complexes in human leukaemia cells.
    Padget K; Stewart A; Charlton P; Tilby MJ; Austin CA
    Biochem Pharmacol; 2000 Sep; 60(6):817-21. PubMed ID: 10930536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of interaction of the acetyltransferase region of p300 and the DNA-binding domain of Sp1 on and through DNA binding.
    Suzuki T; Kimura A; Nagai R; Horikoshi M
    Genes Cells; 2000 Jan; 5(1):29-41. PubMed ID: 10651903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of 6-[[2-(Dimethylamino)ethyl]amino]-3-hydroxy-7H-indeno[2,1-c]quinolin-7-one dihydrochloride (TAS-103)-resistant cell lines.
    Aoyagi Y; Kobunai T; Utsugi T; Wierzba K; Yamada Y
    Jpn J Cancer Res; 2000 May; 91(5):543-50. PubMed ID: 10835500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of XR5944, a novel and potent topoisomerase poison.
    Stewart AJ; Mistry P; Dangerfield W; Bootle D; Baker M; Kofler B; Okiji S; Baguley BC; Denny WA; Charlton PA
    Anticancer Drugs; 2001 Apr; 12(4):359-67. PubMed ID: 11335793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of the dual topoisomerase-I and -II inhibitor TAS-103 and activity against (multi)drug resistant cells.
    Minderman H; Wrzosek C; Cao S; Utsugi T; Kobunai T; Yamada Y; Rustum YM
    Cancer Chemother Pharmacol; 2000; 45(1):78-84. PubMed ID: 10647506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1.
    Loeffler S; Fayard B; Weis J; Weissenberger J
    Int J Cancer; 2005 Jun; 115(2):202-13. PubMed ID: 15688401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
    Rotheneder H; Geymayer S; Haidweger E
    J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAF1 histone acetyltransferase activity in Sp1 activation of the cyclin D1 promoter.
    Hilton TL; Li Y; Dunphy EL; Wang EH
    Mol Cell Biol; 2005 May; 25(10):4321-32. PubMed ID: 15870300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of disease-associated keratin 16 gene expression by epidermal growth factor is regulated through cooperation of transcription factors Sp1 and c-Jun.
    Wang YN; Chang WC
    J Biol Chem; 2003 Nov; 278(46):45848-57. PubMed ID: 12954631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antitumor activity of TAS-103 against freshly-isolated human colorectal cancer.
    Tsunoda T; Tanimura H; Yamaue H; Ishimoto K; Kobunai T; Yamada Y
    Anticancer Res; 2001; 21(6A):3897-902. PubMed ID: 11911266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.